First Part.- How frequent is lung cancer.- Is it still a male problem.- Who is at high risk.- Can you reduce the risk.- Is screening useful.- What are the symptoms.- Which are the initial steps in diagnosis.- What are the major histologic types.- Who is a candidate for surgery.- Who is a candidate for radiotherapy.- Who is a candidate for chemotherapy.- What are the results.- How to support incurable patients.- What are the strategies for prevention?.- Second Part.- Epidemiology and aetiology.- Pathology.- Clinical diagnosis and basic evaluation.- Non-small cell lung cancer: staging and surgery.- Non-small cell lung cancer: radiotherapy and chemotherapy.- Small cell lung cancer.- The role of the general practitioner in treatment.- Strategies for prevention.- References.

The "Europe against Cancer" programme has, from its inception, emphasised the key role which general practitioners must play in the actions necessary to achieve its aim of reduc ing the incidence and the mortality from cancer in the European Community. General practitioners, because of their day-to-day direct and continuing contact with patients, playa role not only in primary prevention and education of patients, but also in motivating their patients to accept secondary prevention and screening, some of it carried out by general practitioners themselves. These preventive activities are in addition to their traditional role in the care and management of patients with cancer at home, and increas ingly, their role in active treatment. In view of the importance of the general practitioner in the "Europe against Cancer" pro gramme, the European Commission, with a view to providing general practitioners with up-to-date useful information, has sponsored the production of this series of publications on organ based cancers, especially written for general practitioners. MICHEL RICHONNIER Coordinator ofthe "Europe against Cancer" programme, Commission ofthe European Communities, Brussels Preface To decrease the death rate of lung cancer is today one of the major challenges of medical doctors all over the world. In Europe alone, one person is dying of lung cancer every two minutes. Accordingly, most physicians will regularly in their career be confronted with a patient being either suspect of or having a lung cancer.